Financial & competing interests disclosure
M Mutz is a founder and shareholder of Amplyx Pharmaceuticals. T Roemer is an employee of Merck & Co. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Additional information
Funding
M Mutz is a founder and shareholder of Amplyx Pharmaceuticals. T Roemer is an employee of Merck & Co. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.